GeneType Identifies 79.5% of People Tested are at Risk of Serious Disease
Genetic Technologies Ltd - American Depositary Shares (GENE)
US:NASDAQ Investor Relations:
gtgcorporate.com/investor-centre
Company Research
Source: GlobeNewswire
CHARLOTTE, N.C., June 25, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and serious disease, is pleased to share the power of the geneType test in identifying risk and improving the health of populations worldwide. Since the geneType Risk Assessment Tests became available, GTG has tested a statistically significant number of people in Australia and the US. These results have revealed a compelling statistic: 79.5% of individuals tested*1 showed an elevated risk for at least one disease. GTG believes this is a significant finding driving increased surveillance and screening which will ultimately lead to early detection, early intervention and, ultimately, save lives. GeneType is revolutionizing healthcare with its pioneering, non-invasive Multi-Risk Test, designed to uncover hidden risks of common yet serious diseases. This state-of-the-art test identifies individuals
Show less
Read more
Impact Snapshot
Event Time:
GENE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GENE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GENE alerts
High impacting Genetic Technologies Ltd - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
GENE
News
- Join Genetic Technologies’ Exclusive Live Investor Webinar and Q&A Session on June 27GlobeNewswire
- Genetic Technologies Expands Operational Capacity in North AmericaGlobeNewswire
- GeneType and Stayhealthy Announce Landmark Distribution Agreement for Revolutionary Multi-Risk TestGlobeNewswire
- GTG Launches Revolutionary geneType Test covering 100% Risk of Breast and Ovarian Cancer [Yahoo! Finance]Yahoo! Finance
- GTG Launches Revolutionary geneType Test covering 100% Risk of Breast and Ovarian CancerGlobeNewswire
GENE
Sec Filings
- 5/29/24 - Form 6-K
- 5/28/24 - Form EFFECT
- 5/20/24 - Form F-1
- GENE's page on the SEC website